Must Watch Stock: Imprimis Pharmaceuticals, Inc. (IMMY)

Galtero Lara
Febrero 1, 2018

Given that its average daily volume over the 30 days has been 490.07K shares a day, this signifies a pretty significant change over the norm.

Imprimis Phar Cmn (NASDAQ:IMMY) shares traded on 14.29% above secure line and closed at $1.92. The stock has a market capitalization of $36.58 Million however its outstanding shares are 19.05 Million. Previously Imprimis Phar Cmn (NASDAQ:IMMY) reported $-0.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $-0.19 by $-0.07 with surprise factor of -36.8%.

Keeping an eyeball on Gross profit Margin, Net profit Margin & Operating Margin, the Gross profit margin of 48.00%; the net profit margin of -60.70% while its Operating margin was -41.90% for Imprimis Pharmaceuticals, Inc.

Wall Street analysts are predicting that Imprimis Phar Cmn (NASDAQ:IMMY) will report earnings per share of $0 in their quarterly report.

Some buy side analysts are also providing their Analysis on Imprimis Pharmaceuticals, Inc., where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it's a HOLD, and 0 analysts rated the stock as Sell. However a year ago for the same quarter the company has reported $-0.48 EPS. While, the analyst predicted that the company could provide an EPS of $-0.19/share. The Low Revenue estimate is $205.35 Million, while High Revenue estimate is $237.2 Million.

More news: Traders Secrets on United Continental Holdings, Inc. (UAL), QUALCOMM Incorporated (QCOM)

Imprimis Pharmaceuticals, Inc. (NASDAQ:IMMY) now has a Weekly Volatility of 12.82% percent while its Monthly Volatility is at 8.71% percent. For the current year the company's revenue estimates are $27.4 Million compared to low analyst estimates of $27.4 Million and high estimates of $27.4 Million according to the prediction of 1 analysts. According to today's trading volume Imprimis Pharmaceuticals, ABOVE its 20-Day Avg. volume with the stock showing ABOVE Abnormal volume in the past 150 days.

While looking at the Stock's Performance, Imprimis Pharmaceuticals, Inc. now shows a Weekly Performance of 16.36%, where Monthly Performance is 24.68%, Quarterly performance is 22.29%, 6 Months performance is -25.58% and yearly performance percentage is -18.64%. However the six-month change in the insider ownership was recorded 0%, as well as three-month change in the institutional ownership was recorded 1.29%.

The company shows its Return on Assets (ROA) value of -57.3%. As of today, the company has a SMA200 (200-day simple moving average) of -20.13 Percent. For the week, the stock is performing 16.36%. While it's Return on Investment (ROI) value is -88.2%.

Year to date (YTD) refers to the period beginning the first day of the current calendar or fiscal year up to the current date. Its price to free cash flow for trailing twelve months is 9.38.

Otros informes por

Discuta este artículo